Federal grants to Pharmain Corporation
Pharmain Corporation in Bothell, Washington received $10.7 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $6.8 million. In fiscal 2025 it was awarded $2.6 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$10.7 million
- Awards3
- Awarded in FY 2025$2.6 million
- Largest award$6.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $992,469 |
| FY 2022 | 2 | $2.0 million |
| FY 2023 | 2 | $2.0 million |
| FY 2024 | 2 | $3.1 million |
| FY 2025 | 1 | $2.6 million |
Programs that fund Pharmain Corporation
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $6.8 million |
| Cancer Treatment Research | 1 | $2.0 million |
| Cardiovascular Diseases Research | 1 | $2.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $10.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Subcutaneous drug development for portal hypertension ascites - abstract: the prevalence of all types of ascites, irrespective of the cause, is 41.7 in 100,000 with 80% of these due to cirrhosis. Ascites is treated with a salt restricted diet and pharmacologic therapy using diuretics. However, in 5% | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 12, 2021 | $6.8 million |
| Development of an immunomodulating peptide as a therapy for osteosarcoma in canine and human - osteosarcoma (OSA) is the most common primary malignancy of bone in children and adolescents, accounting for approximately 5% of all childhood tumors (www.cancer.gov). Osteosarcoma occurs primarily in the | Cancer Treatment Research | September 19, 2023 | $2.0 million |
| Cmc of peptide formulation for the treatment of ards - abstract: without a pandemic such as COVID-19, the prevalence of acute respiratory syndrome (ARDS) associated with acute lung injury (ALI) is estimated to be ~200-240K patients/year in the us, accounting for 3.6-MILLION hospital days per year an | Cardiovascular Diseases Research | May 23, 2022 | $2.0 million |
Questions people ask
How much federal grant money does Pharmain Corporation get?
$10.7 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Pharmain Corporation the most?
The Department of Health and Human Services, with $10.7 million in 3 awards.
What is Pharmain Corporation's largest federal grant?
$6.8 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on August 12, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Pharmain Corporation?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Cancer Treatment Research and Cardiovascular Diseases Research.
Other grant recipients in Bothell
- Washington State Board for Community & Technical Colleges
- Washington Manufacturing Services
- Athira Pharma, Inc.
- Remmie, Inc
- Storedgeai LLC
- Lamprogen, Inc
- Bering Sea Fisheries Research Foundation
- Emissol LLC
Largest federal grant recipients in Washington · Federal grants in Washington